Biotechnology & Biopharmaceutical Applications

A global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics.

Formerly known as GE Healthcare, Cytiva provides integrated solutions in biotechnology research and biomolecules production. Cytiva covers the fields of both upstream and downstream applications, such as cell line development and cell culture using fermenters and bioreactors, and provides a plethora of culture media and solutions. Whereas downstream applications include filtration, separation and analysis with fast protein liquid chromatography, molecular imaging as well as kinetic and affinity assays can be performed through the Biacore SPR platform.

Find out more:

• Bioprocessing | Cytiva
• Protein Research | Cytiva
• Lab filtration | Cytiva
• Cell and gene therapy | Cytiva
• Genomics | Cytiva
• Diagnostics | Cytiva

A leader in solid-phase peptide synthesis (SPPS) in research and biopharmaceutical development.

Gyros Protein Technologies provides solutions for solid-phase peptide synthesis (SPPS) in research and biopharmaceutical development and bioanalysis, especially immunoassays, with key interests in increasing biomolecule performance and productivity. Its solutions apply in research, drug discovery, pre-clinical and clinical development, and bioprocess applications. For example, the SPPS systems provide fully automated peptide synthesis solutions in order to achieve high purity peptides in parallel syntheses and on a large scale. The Gyrolab nanoliter-scale immunoassay systems enable our customers to make data driven development decisions with confidence.

Find out more:

• Peptide Synthesizers|Gyros Protein Technologies
• Gyrolab Immunoassay Systems | Automated Immunoassays | Gyros Protein Technologies

A PerkinElmer company that provides cell engineering tools and services in three key areas of therapeutics: basic research, drug discovery and development, and therapeutic applications.

Horizon offers tools and services for screening and cell line engineering that are designed to improve the outcome of drug discovery and development. Its engineered CHO cell lines are designed to enable efficient biologics manufacturing. In base editing, a novel technology that has not yet been clinically validated for use in human therapeutics, Horizon develops tools and services that are based on a highly accurate, novel platform which can be licensed in for gene and cell therapeutic development.

Find out more:

• Gene editing
• Engineered cell lines
• Downstream analysis reagents & consumables
• Knockdown